Overview

AIDA 2000 Guidelines

Status:
Recruiting

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

Prospective use of RT-PCR for PML/RARa might be used to guide a total tehrapy approach in APL, including refined diagnosis, front-line treatment, assessment of response and anticipated salvage therapy for patients who undergo molecular relapse.

Phase:

Phase 2

Details

Lead Sponsor:

Gruppo Italiano Malattie EMatologiche dell'Adulto

Treatments:

Tretinoin